{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:01:58Z","timestamp":1770537718298,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2016,9,4]],"date-time":"2016-09-04T00:00:00Z","timestamp":1472947200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00213-016-4411-x","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T22:33:00Z","timestamp":1472941980000},"page":"3663-3672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports"],"prefix":"10.1007","volume":"233","author":[{"given":"Christoffer","family":"Polcwiartek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torkel","family":"Vang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Hedeg\u00e5rd","family":"Bruhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasseh","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmi","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,4]]},"reference":[{"key":"4411_CR1","doi-asserted-by":"crossref","unstructured":"Ali Z, Levine B, Ripple M, Fowler DR (2012) Diabetic ketoacidosis: a silent death. Am J Forensic Med Pathol\u00a033:189\u2013193","DOI":"10.1097\/PAF.0b013e31825192e7"},{"key":"4411_CR2","first-page":"642","volume":"43","author":"KM Babu","year":"2005","unstructured":"Babu KM, Ganetsky M, Liang IE, Bird SB, Boyer EW (2005) Pancreatitis and diabetic ketoacidosis. Clin Toxicol (Phila) 43:642","journal-title":"Clin Toxicol (Phila)"},{"key":"4411_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2005-837815","volume":"38","author":"M Bahceci","year":"2005","unstructured":"Bahceci M, Tuzcu A, Bulent C, Cengiz T (2005) Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium. Pharmacopsychiatry 38:105\u2013106","journal-title":"Pharmacopsychiatry"},{"key":"4411_CR4","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","volume":"233","author":"D Baumeister","year":"2016","unstructured":"Baumeister D, Ciufolini S, Mondelli V (2016) Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? Psychopharmacology 233:1575\u20131589","journal-title":"Psychopharmacology"},{"key":"4411_CR5","unstructured":"Bowen E, Holt R, Harrison M (2012) \u03b2-cell-specific effects of the antipsychotic drugs clozapine and haloperidol. Diabet Med\u00a029(Suppl 1):32"},{"key":"4411_CR6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1445-5994.2008.01712.x","volume":"38","author":"S Buchholz","year":"2008","unstructured":"Buchholz S, Morrow AF, Coleman PL (2008) Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms. Intern Med J 38:602\u2013606","journal-title":"Intern Med J"},{"key":"4411_CR7","first-page":"1","volume":"37","author":"D Cohen","year":"2004","unstructured":"Cohen D (2004) Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry 37:1\u201311","journal-title":"Pharmacopsychiatry"},{"key":"4411_CR8","doi-asserted-by":"crossref","unstructured":"Cohen D, Correll CU (2009) Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need. J Clin Psychiatry 70:765\u2013766","DOI":"10.4088\/JCP.09ac05255"},{"key":"4411_CR9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00125-005-1879-z","volume":"48","author":"D Cohen","year":"2005","unstructured":"Cohen D, Batstra MR, Gispen-de Wied CC (2005) Immunological characteristics of diabetes in schizophrenia. Diabetologia 48:1941\u20131942","journal-title":"Diabetologia"},{"key":"4411_CR10","doi-asserted-by":"crossref","unstructured":"Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF (2012) Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. J Clin Psychiatry 73:1307\u20131312","DOI":"10.4088\/JCP.11r06977"},{"key":"4411_CR11","doi-asserted-by":"crossref","unstructured":"Crespo-Facorro B, Carrasco-Mar\u00edn E, P\u00e9rez-Iglesias R, Pelayo-Ter\u00e1n JM, Fernandez-Prieto L, Leyva-Cobi\u00e1n F, V\u00e1zquez-Barquero JL (2008) Interleukin-12 plasma levels in drug-na\u00efve patients with a first episode of psychosis: effects of antipsychotic drugs. Psychiatry Res 158:206\u2013216","DOI":"10.1016\/j.psychres.2006.08.005"},{"key":"4411_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/appi.psy.41.4.369","volume":"41","author":"PE Croarkin","year":"2000","unstructured":"Croarkin PE, Jacobs KM, Bain BK (2000) Diabetic ketoacidos is associated with risperidone treatment? Psychosomatics 41:369\u2013370","journal-title":"Psychosomatics"},{"key":"4411_CR13","first-page":"282","volume":"55","author":"K Dahri","year":"2002","unstructured":"Dahri K, Brown G (2002) Combined olanzapine- and risperidone-induced diabetic ketoacidosis. Can J Hosp Pharm 55:282\u2013283","journal-title":"Can J Hosp Pharm"},{"key":"4411_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2015.05.003","volume":"284","author":"D Franz","year":"2015","unstructured":"Franz D, Contreras F, Gonzalez H, Prado C, Elgueta D, Figueroa C, Pacheco R (2015) Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production. J Neuroimmunol 284:18\u201329","journal-title":"J Neuroimmunol"},{"key":"4411_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001250051573","volume":"44","author":"EA Gale","year":"2001","unstructured":"Gale EA, Gillespie KM (2001) Diabetes and gender. Diabetologia 44:3\u201315","journal-title":"Diabetologia"},{"key":"4411_CR16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc14-2538","volume":"38","author":"A Galler","year":"2015","unstructured":"Galler A, Bollow E, Meusers M, Bartus B, Nake A, Haberland H, Schober E, Holl RW (2015) Comparison of glycemic and metabolic control in youth with type 1 diabetes with and without antipsychotic medication: analysis from the nationwide German\/Austrian Diabetes Survey (DPV). Diabetes Care 38:1051\u20131057","journal-title":"Diabetes Care"},{"key":"4411_CR17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0033-3182(99)71210-7","volume":"40","author":"LE Goldstein","year":"1999","unstructured":"Goldstein LE, Sporn J, Brown S, Kim H, Finkelstein J, Gaffey GK, Sachs G, Stern TA (1999) New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment. Psychosomatics 40:438\u2013443","journal-title":"Psychosomatics"},{"key":"4411_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-013-2982-3","volume":"226","author":"MD Guenette","year":"2013","unstructured":"Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ (2013) Atypical antipsychotics and diabetic ketoacidosis: a review. Psychopharmacology 226:1\u201312","journal-title":"Psychopharmacology"},{"key":"4411_CR19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.v68n0407","volume":"68","author":"DC Henderson","year":"2007","unstructured":"Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC (2007) Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry 68:533\u2013541","journal-title":"J Clin Psychiatry"},{"key":"4411_CR20","doi-asserted-by":"crossref","unstructured":"Howes OD, Rifkin L (2004) Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine. J Psychopharmacol\u00a018:435\u2013437","DOI":"10.1177\/026988110401800317"},{"key":"4411_CR21","first-page":"782","volume":"31","author":"Y Huang","year":"2010","unstructured":"Huang Y, Qiu AW, Peng YP, Liu Y, Huang HW, Qiu YH (2010) Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function. Neuro Endocrinol Lett 31:782\u2013791","journal-title":"Neuro Endocrinol Lett"},{"key":"4411_CR22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.52.4.1052","volume":"52","author":"V Hyttinen","year":"2003","unstructured":"Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052\u20131055","journal-title":"Diabetes"},{"key":"4411_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1507\/endocrj.43.605","volume":"43","author":"H Ikegami","year":"1996","unstructured":"Ikegami H, Ogihara T (1996) Genetics of insulin-dependent diabetes mellitus. Endocr J 43:605\u2013613","journal-title":"Endocr J"},{"key":"4411_CR24","doi-asserted-by":"crossref","unstructured":"Jin H, Meyer JM, Jeste DV (2002) Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry\u00a014:59\u201364","DOI":"10.3109\/10401230209147399"},{"key":"4411_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2004.03.024","volume":"71","author":"H Jin","year":"2004","unstructured":"Jin H, Meyer JM, Jeste DV (2004) Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 71:195\u2013212","journal-title":"Schizophr Res"},{"key":"4411_CR26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archpsyc.64.8.894","volume":"64","author":"H Juvonen","year":"2007","unstructured":"Juvonen H, Reunanen A, Haukka J, Muhonen M, Suvisaari J, Araj\u00e4rvi R, Partonen T, L\u00f6nnqvist J (2007) Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch Gen Psychiatry 64:894\u2013899","journal-title":"Arch Gen Psychiatry"},{"key":"4411_CR27","doi-asserted-by":"crossref","first-page":"a007690","DOI":"10.1101\/cshperspect.a007690","volume":"2","author":"M Knip","year":"2012","unstructured":"Knip M, Simell O (2012) Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med 2:a007690","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4411_CR28","doi-asserted-by":"crossref","unstructured":"Kustrimovic N, Rasini E, Legnaro M, Marino F, Cosentino M (2014) Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. J NeuroImmune Pharmacol 9:302\u2013312","DOI":"10.1007\/s11481-014-9541-5"},{"key":"4411_CR29","doi-asserted-by":"crossref","unstructured":"Laugesen E, \u00d8stergaard JA, Leslie RD (2015) Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med\u00a032:843\u2013852","DOI":"10.1111\/dme.12700"},{"key":"4411_CR30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2016","unstructured":"Levite M (2016) Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol (Oxf) 216:42\u201389","journal-title":"Acta Physiol (Oxf)"},{"key":"4411_CR31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygeno.2013.12.007","volume":"103","author":"M Lopes","year":"2014","unstructured":"Lopes M, Kutlu B, Miani M, Bang-Berthelsen CH, St\u00f8rling J, Pociot F, Goodman N, Hood L, Welsh N, Bontempi G, Eizirik DL (2014) Temporal profiling of cytokine-induced genes in pancreatic beta-cells by meta-analysis and network inference. Genomics 103:264\u2013275","journal-title":"Genomics"},{"key":"4411_CR32","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1592\/phco.28.9.1198","volume":"28","author":"ZH Makhzoumi","year":"2008","unstructured":"Makhzoumi ZH, McLean LP, Lee JH, Ibe AI (2008) Diabetic ketoacidosis associated with aripiprazole. Pharmacotherapy 28:1198\u20131202","journal-title":"Pharmacotherapy"},{"key":"4411_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2012.06.003","volume":"251","author":"LCA Martins","year":"2012","unstructured":"Martins LCA, Rocha NP, Torres KCL, dos Santos RR, Fran\u00e7a GS, de Moraes EN, Mukhamedyarov MA, Zefirov AL, Rizvanov AA, Kiyasov AP, Vieira LB, Guimar\u00e3es MM, Yalva\u00e7 ME, Teixeira AL, Bicalho MAC, Janka Z, Romano-Silva MA, Palot\u00e1s A, Reis HJ (2012) Disease-specific expression of the serotonin-receptor 5-HT(2C) in natural killer cells in Alzheimer\u2019s dementia. J Neuroimmunol 251:73\u201379","journal-title":"J Neuroimmunol"},{"key":"4411_CR34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00125-005-0069-3","volume":"49","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Ritzel RA, Maedler K, Gurlo T, Butler PC (2006) Increased vulnerability of newly forming beta cells to cytokine-induced cell death. Diabetologia 49:83\u201389","journal-title":"Diabetologia"},{"issue":"Suppl 3","key":"4411_CR35","first-page":"S507","volume":"25","author":"M Nahas","year":"2010","unstructured":"Nahas M, Krishna V, Lohiya S (2010) Diabetic ketoacidosis presenting in an \u2018atypical\u2019 way. J Gen Intern Med 25(Suppl 3):S507","journal-title":"J Gen Intern Med"},{"key":"4411_CR36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/RRS-200029981","volume":"24","author":"KA Neve","year":"2004","unstructured":"Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165\u2013205","journal-title":"J Recept Signal Transduct Res"},{"key":"4411_CR37","doi-asserted-by":"crossref","unstructured":"Nielsen J, Correll CU, Manu P, Kane JM (2013) Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Clin Psychiatry\u00a074:603\u2013613 quiz 613","DOI":"10.4088\/JCP.12r08064"},{"key":"4411_CR38","doi-asserted-by":"crossref","unstructured":"Nielsen J, Skadhede S, Correll CU (2010) Antipsychotics associated with the development of type 2 diabetes in antipsychotic-na\u00efve schizophrenia patients. Neuropsychopharmacology\u00a035:1997\u20132004","DOI":"10.1038\/npp.2010.78"},{"key":"4411_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TEN.0b013e318198b9b8","volume":"19","author":"BU Nwosu","year":"2009","unstructured":"Nwosu BU, Hardy OT, Angelescu A, Soyka LA, Lee MM (2009) Do atypical antipsychotic agents trigger autoimmune diabetes? Endocrinologist 19:85\u201387","journal-title":"Endocrinologist"},{"key":"4411_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2014.00117","volume":"5","author":"R Pacheco","year":"2014","unstructured":"Pacheco R, Contreras F, Zouali M (2014) The dopaminergic system in autoimmune diseases. Front Immunol 5:117","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"4411_CR41","first-page":"A681","volume":"60","author":"VB Patel","year":"2011","unstructured":"Patel VB, Bulchandani DG, Kyner JL (2011) Severe insulin resistance associated with atypical antipsychotic agents. Diabetes 60(Suppl 1):A681","journal-title":"Diabetes"},{"key":"4411_CR42","first-page":"737","volume":"153","author":"GA Peterson","year":"1996","unstructured":"Peterson GA, Byrd SL (1996) Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 153:737\u2013738","journal-title":"Am J Psychiatry"},{"key":"4411_CR43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14740338.2016.1161021","volume":"15","author":"C Polcwiartek","year":"2016","unstructured":"Polcwiartek C, Kragholm K, Schjerning O, Graff C, Nielsen J (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opin Drug Saf 15:679\u2013688","journal-title":"Expert Opin Drug Saf"},{"key":"4411_CR44","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00213-015-4024-9","volume":"232","author":"C Polcwiartek","year":"2015","unstructured":"Polcwiartek C, Sneider B, Graff C, Taylor D, Meyer J, Kanters JK, Nielsen J (2015) The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach. Psychopharmacology 232:3297\u20133308","journal-title":"Psychopharmacology"},{"key":"4411_CR45","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.1103096","volume":"188","author":"C Prado","year":"2012","unstructured":"Prado C, Contreras F, Gonz\u00e1lez H, D\u00edaz P, Elgueta D, Barrientos M, Herrada AA, Lladser \u00c1, Bernales S, Pacheco R (2012) Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. J Immunol 188:3062\u20133070","journal-title":"J Immunol"},{"key":"4411_CR46","unstructured":"Reddymasu S, Bahta E, Levine S, Manas K, Slay LE (2006) Elevated lipase and diabetic ketoacidosis associated with aripiprazole. JOP 7:303\u2013305"},{"key":"4411_CR47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpsychires.2005.11.007","volume":"41","author":"M Riedel","year":"2007","unstructured":"Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, M\u00f6ller HJ, M\u00fcller N (2007) Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 41:3\u20137","journal-title":"J Psychiatr Res"},{"key":"4411_CR48","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","volume":"140","author":"R R\u00f8ge","year":"2012","unstructured":"R\u00f8ge R, M\u00f8ller BK, Andersen CR, Correll CU, Nielsen J (2012) Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? Schizophr Res 140:204\u2013213","journal-title":"Schizophr Res"},{"key":"4411_CR49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4045\/tidsskr.09.0698","volume":"130","author":"HA S\u00e6verud","year":"2010","unstructured":"S\u00e6verud HA, Gerlyng P (2010) From prison with coma. Tidsskr Nor Legeforen 130:284\u2013285","journal-title":"Tidsskr Nor Legeforen"},{"key":"4411_CR50","doi-asserted-by":"crossref","unstructured":"Sato Y, Yasui-Furukori N, Kaneko S, Moriyama T (2008) New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone. Prog Neuropsychopharmacol Biol Psychiatry\u00a032:577\u2013578","DOI":"10.1016\/j.pnpbp.2007.08.039"},{"key":"4411_CR51","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/diabetes.49.11.1801","volume":"49","author":"S Seewaldt","year":"2000","unstructured":"Seewaldt S, Thomas HE, Ejrnaes M, Christen U, Wolfe T, Rodrigo E, Coon B, Michelsen B, Kay TW, von Herrath MG (2000) Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49:1801\u20131809","journal-title":"Diabetes"},{"key":"4411_CR52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.genhosppsych.2008.06.007","volume":"30","author":"F Sirois","year":"2008","unstructured":"Sirois F (2008) New-onset diabetic ketoacidosis associated with quetiapine: a case report. Gen Hosp Psychiatry 30:587\u2013588","journal-title":"Gen Hosp Psychiatry"},{"key":"4411_CR53","doi-asserted-by":"crossref","unstructured":"Smith H, Kenney-Herbert J, Knowles L (1999) Clozapine-induced diabetic ketoacidosis. Aust N Z J Psychiatry\u00a033:120\u2013121","DOI":"10.1080\/0004867900027"},{"key":"4411_CR54","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.SMJ.0000078649.46905.B5","volume":"96","author":"SA Tavakoli","year":"2003","unstructured":"Tavakoli SA, Arguisola MS (2003) Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine. South Med J 96:729\u2013730","journal-title":"South Med J"},{"key":"4411_CR55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00024677-200302020-00003","volume":"2","author":"GE Umpierrez","year":"2003","unstructured":"Umpierrez GE, Kitabchi AE (2003) Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol 2:95\u2013108","journal-title":"Treat Endocrinol"},{"key":"4411_CR56","doi-asserted-by":"crossref","first-page":"d4092","DOI":"10.1136\/bmj.d4092","volume":"343","author":"JA Usher-Smith","year":"2011","unstructured":"Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM (2011) Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 343:d4092","journal-title":"BMJ"},{"key":"4411_CR57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"TL Belle van","year":"2011","unstructured":"van Belle TL, Coppieters KT, von Herrath MG (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91:79\u2013118","journal-title":"Physiol Rev"},{"key":"4411_CR58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0885066606295823","volume":"22","author":"MK Varma","year":"2007","unstructured":"Varma MK, Connolly K, Fulton B (2007) Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature. J Intensive Care Med 22:52\u201355","journal-title":"J Intensive Care Med"},{"key":"4411_CR59","doi-asserted-by":"crossref","unstructured":"Watkins J, Ray S, Gillion A, Finch C (2011) Case report - aripiprazole-induced diabetic ketoacidosis: remaining vigilant. Hosp Pharm 46:432\u2013435","DOI":"10.1310\/hpj4606-432"},{"key":"4411_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00331-0","volume":"59","author":"DR Wilson","year":"2003","unstructured":"Wilson DR, D\u2019Souza L, Sarkar N, Newton M, Hammond C (2003) New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophr Res 59:1\u20136","journal-title":"Schizophr Res"},{"key":"4411_CR61","unstructured":"Wong JO, Fu JC, Hung GB (2007) Olanzapine-induced diabetic ketoacidosis in a Chinese man.\u00a0Hong Kong Med J\u00a013:73\u201374"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4411-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4411-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T05:54:05Z","timestamp":1568354045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4411-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,4]]},"references-count":61,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["4411"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4411-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,4]]}}}